Autor: |
Nagler, Arnon, Labopin, Myriam, Salmenniemi, Urpu, Wu, Depei, Blaise, Didier, Rambaldi, Alessandro, Remenyi, Peter, Forcade, Edouard, de Latour, Régis Peffault, Chevallier, Patrice, Borne, Peter von dem, Burns, David, Schmid, Christoph, Maertens, Johan, Kroger, Nicolaus, Bug, Gesine, Aljurf, Mahmoud, Vydra, Jan, Halaburda, Kazimierz, Ciceri, Fabio, Mohty, Mohamad |
Zdroj: |
Transplantation and Cellular Therapy; February 2024, Vol. 30 Issue: 2, Number 2 Supplement 1 pS337-S338, 2p |
Abstrakt: |
Allogeneic transplantation (HSCT) is usually not indicated in favorable risk AML at CR1due to transplant-related mortality. However, in recent years, HSCTs are with significantly lower mortality. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|